Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zenas BioPharma Inc.

11.12
+1.5115.71%
Post-market: 11.330.2100+1.89%19:56 EDT
Volume:198.09K
Turnover:2.12M
Market Cap:465.20M
PE:-1.59
High:11.28
Open:9.76
Low:9.61
Close:9.61
Loading ...
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 21, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 16, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 06, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 28, 2024

Correspondence

Form CORRESP - Correspondence